Shenglan Huang
- Topics
- Ferroptosis and cancer prognosis (9 papers)Cancer Immunotherapy and Biomarkers (6 papers)Hepatocellular Carcinoma Treatment and Prognosis (5 papers)
- Cited by
- HepatologyCancer ResearchOncology
- Partner nations
- China
In The Last Decade
Shenglan Huang
20 papers receiving 291 citations
Peers
Comparison fields: 5 of 54
- Molecular Biology 150
- Cancer Research 95
- Oncology 69
- Pulmonary and Respiratory Medicine 66
- Hepatology 60
Countries citing papers authored by Shenglan Huang
This map shows the geographic impact of Shenglan Huang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shenglan Huang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shenglan Huang more than expected).
Fields of papers citing papers by Shenglan Huang
This network shows the impact of papers produced by Shenglan Huang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shenglan Huang. The network helps show where Shenglan Huang may publish in the future.
Co-authorship network of co-authors of Shenglan Huang
This figure shows the co-authorship network connecting the top 25 collaborators of Shenglan Huang. A scholar is included among the top collaborators of Shenglan Huang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shenglan Huang. Shenglan Huang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 2 | |
| 4 | 3 | |
| 5 | 3 | |
| 6 | 0 | |
| 7 | 7 | |
| 8 | 21 | |
| 9 | 6 | |
| 10 | 7 | |
| 11 | 4 | |
| 12 | 8 | |
| 13 | 10 | |
| 14 | 36 | |
| 15 | 30 | |
| 16 | 24 | |
| 17 | 12 | |
| 18 | 15 | |
| 19 | 52 | |
| 20 | 11 |
About Shenglan Huang
Shenglan Huang is a scholar working on Cancer Research, Hepatology and Oncology, having authored 23 papers that have together received 295 indexed citations. Recurring topics across this work include Ferroptosis and cancer prognosis (9 papers), Cancer Immunotherapy and Biomarkers (6 papers) and Hepatocellular Carcinoma Treatment and Prognosis (5 papers). The work is most often cited by research in Hepatology (60 citations), Cancer Research (95 citations) and Oncology (69 citations). Shenglan Huang has collaborated with scholars based in China. Frequent co-authors include Jianbing Wu, Lingling Zhuang, Dan Li, Li‐Ying Sun, Mao Ye, Zhifeng Zhou, Shuping Chen, Yunbin Ye, Mingshui Chen and Wansong Lin. Their work appears in journals such as Journal of Clinical Oncology, Scientific Reports and Frontiers in Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.